Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML.

Shumilov, Evgenii; Flach, Johanna; Joncourt, Raphael; Porret, Naomi; Wiedemann, Gertrud; Novak, Urban; Gfeller, Eva; Jeker, Barbara; Amstutz, Ursula; Pabst, Thomas; Bacher, Vera (2019). Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML. Leukemia & lymphoma, 60(10), pp. 2588-2590. Taylor & Francis 10.1080/10428194.2019.1585838

Full text not available from this repository. (Request a copy)

Item Type:	Journal Article (Further Contribution)
Division/Institute:	04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Haematology and Central Haematological Laboratory 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology
UniBE Contributor:	Joncourt, Raphael, Porret, Naomi, Wiedemann, Gertrud, Novak, Urban, Jeker, Barbara, Amstutz, Ursula, Pabst, Thomas Niklaus, Bacher, Vera Ulrike
Subjects:	600 Technology > 610 Medicine & health
ISSN:	1029-2403
Publisher:	Taylor & Francis
Language:	English
Submitter:	Rebeka Gerber
Date Deposited:	01 Nov 2019 15:10
Last Modified:	02 Mar 2023 23:32
Publisher DOI:	10.1080/10428194.2019.1585838
PubMed ID:	30998101
URI:	https://boris.unibe.ch/id/eprint/134266